Clear Search

Showing 1 result for “Cicirello S”.

July 2023

Eficácia comparativa de baricitinibe em primeira linha em pacientes com artrite reumatoide no conjunto de dados OPAL australiano

ACR Open Rheumatol. 2023;5(7):345-353 doi 10.1002/acr2.11577

Cicirello, et al. present results showing that baricitinib is comparable in treatment persistence with TNF inhibitors. However, treatment persistence up to 24 months was significantly longer for baricitinib, but the effect size of one month is not clinically meaningful.